Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health. 2022;4:e8–17.

CAS  PubMed  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw. 2020;18:806–15.

PubMed  Google Scholar 

van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575–82.

PubMed  Google Scholar 

Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.

PubMed  PubMed Central  Google Scholar 

Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012;13:679–87.

PubMed  Google Scholar 

Zaborowski A, Stakelum A, Winter DC. Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Br J Surg. 2019;106:979–87.

CAS  PubMed  Google Scholar 

Smith RK, Fry RD, Mahmoud NN, Paulson EC. Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision. Int J Colorectal Dis. 2015;30:769–74.

PubMed  Google Scholar 

Li J, Li L, Yang L, Yuan J, Lv B, Yao Y, et al. Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Oncotarget. 2016;7:44857–70.

PubMed  PubMed Central  Google Scholar 

Araujo RO, Valadão M, Borges D, Linhares E, de Jesus JP, Ferreira CG, et al. Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. Eur J Surg Oncol. 2015;41:1456–63.

CAS  PubMed  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16:874–901.

PubMed  PubMed Central  Google Scholar 

Lambregts DMJ, van Heeswijk MM, Delli Pizzi A, van Elderen SGC, Andrade L, Peters N, et al. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching. Eur Radiol. 2017;27:4445–54.

PubMed  Google Scholar 

Iannicelli E, Di Pietropaolo M, Pilozzi E, Osti MF, Valentino M, Masoni L, et al. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Abdom Radiol. 2016;41:1906–17.

Google Scholar 

Shen F, Chen L, Li Z, Lu H, Chen Y, Wang Z, et al. The usefulness of b value threshold map in the evaluation of rectal adenocarcinoma. Abdom Radiol. 2020;45:332–41.

Google Scholar 

Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology. 2013;268:330–44.

PubMed  Google Scholar 

Siddiqui MR, Gormly KL, Bhoday J, Balyansikova S, Battersby NJ, Chand M, et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol. 2016;71:854–62.

CAS  PubMed  Google Scholar 

Yoen H, Park HE, Kim SH, Yoon JH, Hur BY, Bae JS, et al. Prognostic value of tumor regression grade on MR in rectal cancer: a large-scale, single-center experience. Korean J Radiol. 2020;21:1065–76.

PubMed  PubMed Central  Google Scholar 

Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–25.

CAS  PubMed  PubMed Central  Google Scholar 

Moon SJ, Cho SH, Kim GC, Kim WH, Kim HJ, Shin KM, et al. Complementary value of pre-treatment apparent diffusion coefficient in rectal cancer for predicting tumor recurrence. Abdom Radiol. 2016;41:1237–44.

Google Scholar 

Salerno G, Chandler I, Wotherspoon A, Thomas K, Moran B, Brown G. Sites of surgical wasting in the abdominoperineal specimen. Br J Surg. 2008;95:1147–54.

CAS  PubMed  Google Scholar 

Yuan Y, Zheng K, Zhou L, Chen F, Zhang S, Lu H, et al. Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer. Int J Colorectal Dis. 2023;38:40.

PubMed  Google Scholar 

Takahashi Y, Hayano K, Ohira G, Imanishi S, Hanaoka T, Watanabe H, et al. Histogram analysis of diffusion-weighted MR imaging as a biomarker to predict survival of surgically treated colorectal cancer patients. Dig Dis Sci. 2021;66:1227–32.

PubMed  Google Scholar 

Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, et al. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncol. 2017;56:813–8.

PubMed  Google Scholar 

Zhang G, Xu Z, Zheng J, Wang M, Ren J, Wei X, et al. Prognostic value of multi b-value DWI in patients with locally advanced rectal cancer. Eur Radiol. 2023;33:1928–37.

CAS  PubMed  Google Scholar 

Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92:20180655.

PubMed  PubMed Central  Google Scholar 

Zhang G, Xu Z, Zheng J, Wang M, Ren J, Wei X, et al. Ultra-high b-Value DWI in predicting progression risk of locally advanced rectal cancer: a comparative study with routine DWI. Cancer Imaging. 2023;23:59.

PubMed  PubMed Central  Google Scholar 

Prampolini F, Taschini S, Pecchi A, Sani F, Spallanzani A, Gelsomino F, et al. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion. Abdom Radiol. 2020;45:2941–9.

Google Scholar 

Gall P, Kasibhatla R and Meyer H. Improved lesion visualization using B-value maps based on thresholded DWI images. Paper presented at the ISMRM. 2014. #6639

Zhao N, Ma C, Ye X, Danie N, Fu C, Hao Q, et al. The feasibility of b-value maps based on threshold DWI for detection of breast cancer: a case-control STROBE compliant study. Medicine. 2019;98: e17640.

PubMed  PubMed Central  Google Scholar 

Chen F, Zhang S, Ma X, Chen Y, Wang Z, Zhu Y, et al. Prediction of tumor budding in patients with rectal adenocarcinoma using b-value threshold map. Eur Radiol. 2023;33:1353–63.

CAS  PubMed  Google Scholar 

Zhang H, Sun G, Zheng K, Lou Z, Gao XH, Meng RG, et al. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer. ANZ J Surg. 2021;91:E190–5.

PubMed  Google Scholar 

Jang TY, Yu CS, Yoon YS, Lim SB, Hong SM, Kim TW, et al. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer. Dis Colon Rectum. 2012;55:1024–31.

PubMed  Google Scholar 

Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835–44.

PubMed  Google Scholar 

Lu Z, Cheng P, Yang F, Zheng Z, Wang X. Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection. Chin J Cancer Res. 2018;30:272–81.

PubMed  PubMed Central  Google Scholar 

Xiao Y, Lu J, Xiong G, Wu B, Lin G, Zhao L, et al. Postoperative pathological staging correlates the prognosis of rectal cancer after neoadjuvant chemoradiotherapy. Zhonghua Wai Ke Za Zhi. 2014;52:99–104.

PubMed  Google Scholar 

Koca D, Binicier C, Oztop I, Yavuzsen T, Ellidokuz H, Yilmaz U. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer. J buon. 2012;17:291–8.

CAS  PubMed  Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8.

PubMed  Google Scholar 

Wang C, Chen J, Zheng N, Zheng K, Zhou L, Zhang Q, et al. Predicting the risk of distant metastasis in patients with locally advanced rectal cancer using model based on pre-treatment T2WI-based radiomic features plus postoperative pathological stage. Front Oncol. 2023;13:1109588.

PubMed  PubMed Central  Google Scholar 

Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–23.

PubMed  Google Scholar 

Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95:229–36.

CAS  PubMed  Google Scholar 

Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25:1347–55.

PubMed